Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection

Journal of Clinical Investigation

Volumn 98, Issue 6, 1996, Pages 1432-1440

  Rehermann, Barbara ^a   Chang, Kyong Mi ^a   McHutchison, John G ^a   Kokka, Robert ^b   Houghton, Michael ^b   Chisari, Francis V ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

cytotoxic T lymphocyte; hepatitis C virus; interferon; viral clearance; viral persistence

Indexed keywords

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

EID: 0029778817     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118931     Document Type: Article

References (31)

1. Choo, Q.-L., G. Kuo, A.J. Weiner, L.R. Overby, D.W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (Wash. DC). 244:359-362.
2. Houghton, M., A. Weiner, J. Han, G. Kuo, and Q.-L. Choo. 1990. Molecular biology of the hepatitis C virus: implications for diagnosis, development and control of viral disease. Hepatology. 14:381-388.
3. Kuo, G., Q.-L. Choo, H.J. Alter, G.I. Gitnick, A.G. Redeker, R.H. Purcell, T. Miyamura, J.L. Dienstag, M.J. Alter, C.E. Stevens, et al. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (Wash. DC). 244:362-364.
4. Choo, Q.-L., A.J. Weiner, L.R. Overby, G. Kuo, M. Houghton, and D.W. Bradley. 1990. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br. Med. Bull. 46:423-441.
5. Saito, I., T. Miyamura, A. Ohbayashi, H. Harada, T. Katayama, S. Kikuchi, Y. Watanabe, S. Koi, M. Onji, Y. Ohta, Q.-L. Choo, M. Houghton, and G. Kuo. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 87:6547-6549.
6. Nishioka, K., J. Watanabe, S. Furuta, E. Tanaka, S. Iino, H. Suzuki, T. Tsuji, M. Yano, G. Kuo, Q.-L. Choo, et al. 1991. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer (Phila.). 67:429-433.
7. Zinkernagel, R.M., and P.C. Doherty. 1979. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity. Adv. Immunol. 19:51-74.
8. Chisari, F.V., and C. Ferrari. 1996. Immunobiology and pathogenesis of viral hepatitis. In Viral Pathogenesis. N. Nathenson, R. Ahmed, F. Gonzalez-Scarano, D. Griffin, K. Holmes, F.A. Murphy, and H.L. Robinson, editors. J.B. Lippincott Co., Philadelphia, PA. In press.
9. Cerny, A., C. Ferrari, and F.V. Chisari. 1994. The class I restricted cytotoxic T lymphocyte response to predetermined epitopes in the hepatitis B and C viruses. In Current Topics in Microbiology and Immunology. M.B.A. Oldstone, editor. Springer-Verlag GmbH & Co., Heidelberg, Germany. 169-186.
10. Shirai, M., H. Okada, M. Nishioka, T. Akatsuka, C. Wychowski, R. Houghten, C.D. Pendelton, S.M. Feinstone, and J.A. Berzofsky. 1994. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J. Virol. 68:3334-3342.
11. Kita, H., T. Moriyama, T. Kaneko, I. Harase, M. Nomura, H. Miura, I. Nakamura, Y. Yazaki, and M. Imawari. 1993. HLA-B44-restricted cytotoxic T lymphocyte recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology. 18:1039-1044.
12. Cerny, A., J.G. McHutchison, C. Pasquinelli, M.E. Brown, M.A. Brothers, B. Grabscheid, P. Fowler, M. Houghton, and F.V. Chisari. 1995. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Invest. 95:521-530.
13. Battegay, M., J. Fikes, A.M. Di Bisceglie, P.A. Wentworth, A. Sette, E. Celis, W.-M. Ching, A. Grakoui, C.M. Rice, K. Kurokohchi, J.A. Berzofsky, J.H. Hoofnagle, S.M. Feinstone, and T. Akatsuka. 1995. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J. Virol. 69:2462-2470.
14. Shirai, M., T. Arichi, M. Nishioka, T. Nomura, K. Ikeda, K. Kawanishi, V.H. Engelhard, S.M. Feinstone, and J.A. Berzofsky. 1995. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J. Immunol. 154:2733-2742.
15. Koziel, M.J., D. Dudley, J.T. Wong, J. Dienstag, M. Houghton, R. Ralston, and B.D. Walker. 1992. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 149:3339-3344.
16. Koziel, J.M., D. Dudley, N. Afdhal, Q.L. Choo, M. Houghton, R. Ralston, and B.D. Walker. 1993. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67:7522-7532.
17. Koziel, M.J., D. Dudley, N. Afdhal, A. Grakoul, C.M. Rice, Q.-L. Choo, M. Houghton, and B.D. Walker. 1995. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J. Clin. Invest. 96:2311-2321.
18. Weiner, A., A.L. Erickson, J. Kansopon, K. Crawford, E. Muchmore, A.L. Hughes, M. Houghton, and C.M. Walker. 1995. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl. Acad. Sci. USA. 92:2755-2759.
19. Simmonds, P. 1995. Variability of Hepatitis C Virus. Hepatology. 21: 570-583.
20. Mosmann, T.R. 1994. Cytokine pattern during the progression to AIDS. Science (Wash. DC). 265:193-194.
21. Vitiello, A., D. Marchesini, J. Furze, L.A. Sherman, and R.W. Chesnut. 1991. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med. 173:1007-1015.
22. Choo, Q.L., K.H. Richman, J.H. Han, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, A. Medina-Selby, P.J. Barr, et al. 1991. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA. 88:2451-2455.
23. Rehermann, B., D. Lau, J.H. Hoofnagle, and F.V. Chisari. 1996. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection J. Clin. Invest. 97:1655-1665.
24. Wentworth, P.A., E. Celis, C. Crimi, S. Stitely, L. Hale, V. Tsai, H.M. Serra, M.-F. del Guercio, B. Livingston, D. Alazard, et al. 1995. In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides. Mol. Immunol. 32:602-612.
25. Fazekas, S., and S.T. Groth. 1982. The evaluation of limiting dilution assays. J. Immunol. Methods. 49:11-23.
26. Chomczynski, P., and N. Sacchi. 1987. Single-Step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
27. Chan, S.W., F. McOmish, E.C. Holmes, B. Dow, J.F. Peutherer, E. Follett, P.L. Yap, and P. Simmonds. 1992. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J. Gen. Virol. 73:1131-1141.
28. Stuyver, L., A. Wyseur, W. van Arnhem, F. Lunel, P. Laurent-Puig, J.M. Pawlotsky, B. Kleter, L. Bassit, J. Nkengasong, and L.J. van Doom. 1995. Hepatitis C virus genotyping by means of 5′-UR/core line probe assays and molecular analysis of untypeable samples. Virus Res. 38:137-157.
29. Rehermann, B., K.-M. Chang, J. McHutchison, R. Kokka, M. Houghton, C.M. Rice, and F.V. Chisari. 1996. Differential cytotoxic T lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J. Virol. In press.
30. Guidotti, L.G., T. Ishikawa, M.V. Hobbs, B. Matzke, R. Schreiber, and F.V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:35-36.
31. Tsui, L.V., L.G. Guidotti, T. Ishikawa, and F.V. Chisari. 1995. Post-transcriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte activated hepatocytes. Proc. Natl. Acad. Sci. USA. 92:12398-12402.